Herbas VPB

Spausdinti
EN | LT
LT - COMBINING ANTI-HLA-DR OR ANTI-TROP-2 ANTIBODIES WITH MICROTUBULE INHIBITORS, PARP INHIBITORS, BRUTON KINASE INHIBITORS OR PHOSPHOINOSITIDE 3-KINASE INHIBITORS SIGNIFICANTLY IMPROVES THERAPEUTIC OUTCOME IN CANCER
EN - COMBINING ANTI-HLA-DR OR ANTI-TROP-2 ANTIBODIES WITH MICROTUBULE INHIBITORS, PARP INHIBITORS, BRUTON KINASE INHIBITORS OR PHOSPHOINOSITIDE 3-KINASE INHIBITORS SIGNIFICANTLY IMPROVES THERAPEUTIC OUTCOME IN CANCER

Teisinis statusas

Patentas neįsigaliojo (pagal EPK)

Bibliografiniai duomenys
Tarptautinės patentų klasifikacijos indeksai (TPK)
(51) INT.CL. A61K 39/395 (2006.01)
C07K 16/30 (2013.01)
A61P 35/00 (2006.01)
A61K 39/39558 (2013.01)
C07K 16/30 (2006.01)
C07K 16/2803 (2013.01)
A61K 31/357 (2006.01)
C07K 16/2887 (2013.01)
A61P 35/02 (2006.01)
C07K 16/3007 (2013.01)
A61K2039/505 (2013.01)
A61P 35/04 (2006.01)
A61P 43/00 (2006.01)
A61K2039/545 (2013.01)
C07K 16/28 (2006.01)
C07K2317/24 (2013.01)
A61K 39/00 (2006.01)
C07K2317/73 (2013.01)
A61K 47/68 (2017.01)
C07K2317/732 (2013.01)
A61K 45/06 (2006.01)
C07K2317/94 (2013.01)
A61K 31/337 (2006.01)
A61K 47/6803 (2017.08)
A61K 31/502 (2006.01)
A61K 47/6849 (2017.08)
A61K 31/519 (2006.01)
A61K 47/6851 (2017.08)
A61K 31/52 (2006.01)
A61K 47/6853 (2017.08)
A61K 45/06 (2013.01)
A61K 31/337 (2013.01)
A61K 31/357 (2013.01)
A61K 31/502 (2013.01)
A61K 31/519 (2013.01)
A61K 31/52 (2013.01)
A61P 35/00 (2018.01)
A61P 35/02 (2018.01)
A61P 35/04 (2018.01)
A61P 43/00 (2018.01)
Europos patentas
(11) Patento numeris 3313443
(13) Dokumento rūšis T
(96) Europos patento paraiškos numeris 16815285.8
Europos patento paraiškos padavimo data 2016-06-23
(97) Europos patento paraiškos paskelbimo data 2018-05-02
(45) Paskelbimo apie Europos patento išdavimą data 2023-06-07
(46) Apibrėžties vertimo paskelbimo data
Tarptautinės paraiškos padavimo
(86) Numeris PCT/US2016/038986
Data 2016-06-23
Tarptautinės paraiškos paskelbimo
(87) Numeris WO 2016/210108
Data 2016-12-29
Prioriteto paraiškos
(30) Numeris Data Šalis
201562184331 P 2015-06-25 US
201562201361 P 2015-08-05 US
201562250715 P 2015-11-04 US
201562263134 P 2015-12-04 US
201615069208 2016-03-14 US
Išradėjai
(72)
GOLDENBERG, David M. , US
CARDILLO, Thomas, M. , US
Savininkas
(73) Immunomedics, Inc. , 300 American Road, Morris Plains, NJ 07950, US
Pavadinimas
(54) COMBINING ANTI-HLA-DR OR ANTI-TROP-2 ANTIBODIES WITH MICROTUBULE INHIBITORS, PARP INHIBITORS, BRUTON KINASE INHIBITORS OR PHOSPHOINOSITIDE 3-KINASE INHIBITORS SIGNIFICANTLY IMPROVES THERAPEUTIC OUTCOME IN CANCER
  COMBINING ANTI-HLA-DR OR ANTI-TROP-2 ANTIBODIES WITH MICROTUBULE INHIBITORS, PARP INHIBITORS, BRUTON KINASE INHIBITORS OR PHOSPHOINOSITIDE 3-KINASE INHIBITORS SIGNIFICANTLY IMPROVES THERAPEUTIC OUTCOME IN CANCER